Learn more

UNIV SAITAMA MEDICAL

Overview
  • Total Patents
    174
  • GoodIP Patent Rank
    15,770
  • Filing trend
    ⇧ 77.0%
About

UNIV SAITAMA MEDICAL has a total of 174 patent applications. It increased the IP activity by 77.0%. Its first patent ever was published in 2003. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MINERVA BIOTECHNOLOGIES CORP, FISHER PAUL B and BOSTON MEDICAL CT CORP.

Patent filings per year

Chart showing UNIV SAITAMA MEDICALs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Okazaki Yasushi 25
#2 Katagiri Takenobu 20
#3 Tsukamoto Sho 18
#4 Tsuji Shinnosuke 17
#5 Inoue Satoshi 15
#6 Okuda Akihiko 14
#7 Kagamu Hiroshi 14
#8 Hagiwara Koichi 14
#9 Ikeda Kazuhiro 11
#10 Kato Hidemasa 10

Latest patents

Publication Filing date Title
WO2021020282A1 Antibody recognizing extracellular region of alk2/acvr1
WO2021015249A1 Estimator learning device, estimator learning method, and estimator learning program
WO2020226155A1 Determination device, determination method, and determination program
TW202035701A Method and composition for predicting long-term survival in cancer immunotherapy
TW202035702A Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapy
JP2020198279A Secondary battery refresh effect prediction system, secondary battery refresh effect prediction device, secondary battery refresh effect prediction method, and program
JP2020144012A Stained image estimator learning device, image processing device, stained image estimator learning method, image processing method, stained image estimator learning program, and image processing program
JP2020048426A Screening agents, screening kits, and screening methods for screening at least one agent selected from the group consisting of agents for increasing or reducing the number of cells of frizzled 3 expressing cells, diabetes prevention or treatment agents, insulinoma prevention or treatment agents, and insulin secretion promoters or inhibitors
JP2020027052A Method for aiding determination of affection possibility of gynecology disease, method for collecting data to diagnose affection possibility of gynecology disease, and diagnostic kit of gynecology disease
JP2019198271A Use of double-stranded nucleic acid molecules, dna, vectors, cancer cell growth inhibitors, medicines, and spon1-trim29 fusion genes
JP2019190883A New lung cancer marker
JP2019149987A Method for predicting the effectiveness of radiotherapy to head and neck squamous cell carcinoma
KR20190112027A Immune Biomarkers for Predicting Clinical Effects of Cancer Immunotherapy
JP2019045540A Image processing device, image processing method, and image processing program
EP3474001A1 Test object visualizing device
JP2018175579A Ankle hemodynamics index calculation device, ankle hemodynamics index calculation method, ankle hemodynamics index calculation program, and blood pressure measuring device
JP2018067203A Danger notification device, danger notification method, and calibration method for danger notification device
JP2018038466A Method for evaluating therapeutic effect by medicine in cancer patient, method for creating evaluation data on therapeutic effect, evaluation device for therapeutic effect, and evaluation program for therapeutic effect
JP2018008915A Thickening agent, composition kit, and method for thickening composition
JP2017217037A Applicator for uterine cancer intracavitary irradiation, radiation treatment planning method of uterine cancer and radiation treatment planning device of uterine cancer